Total Payments
$1,051
2024 Payments
$47.92
Companies
18
Transactions
41
Medicare Patients
3,621
Medicare Billing
$2.4M
Payment Breakdown by Category
Food & Beverage$988.71 (94.1%)
Education$61.92 (5.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $988.71 | 40 | 94.1% |
| Education | $61.92 | 1 | 5.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $291.57 | 4 | $0 (2019) |
| Genentech USA, Inc. | $132.08 | 7 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $100.46 | 6 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $94.05 | 5 | $0 (2024) |
| Cardinal Health 108, LLC | $68.73 | 1 | $0 (2017) |
| Myriad Genetic Laboratories, Inc. | $52.35 | 2 | $0 (2023) |
| TESARO, Inc. | $50.66 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $46.14 | 2 | $0 (2022) |
| Seagen Inc. | $41.70 | 2 | $0 (2022) |
| Clovis Oncology, Inc. | $25.59 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.92 | 2 | Tempus AI, Inc ($24.80) |
| 2023 | $28.87 | 1 | Myriad Genetic Laboratories, Inc. ($28.87) |
| 2022 | $91.67 | 4 | GlaxoSmithKline, LLC. ($46.14) |
| 2021 | $42.00 | 2 | Eisai Inc. ($22.35) |
| 2020 | $26.15 | 2 | Mylan Institutional Inc. ($14.83) |
| 2019 | $369.55 | 9 | Intuitive Surgical, Inc. ($291.57) |
| 2018 | $228.48 | 12 | Genentech USA, Inc. ($81.15) |
| 2017 | $215.99 | 9 | Cardinal Health 108, LLC ($68.73) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/18/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $24.80 | General |
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Oncology | ||||||
| 11/09/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: ONCOLOGY | ||||||
| 08/24/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: ONCOLOGY | ||||||
| 06/08/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2022 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Oncology | ||||||
| 04/11/2022 | Myriad Genetic Laboratories, Inc. | PreciseTumor (Device) | Food and Beverage | Cash or cash equivalent | $23.48 | General |
| Category: Tumor DNA Genetic Oncology Analysis | ||||||
| 12/12/2021 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $22.35 | General |
| Category: Oncology | ||||||
| 11/11/2021 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $19.65 | General |
| 12/10/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: ONCOLOGY | ||||||
| 03/10/2020 | Mylan Institutional Inc. | Fulphila (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Oncology | ||||||
| 12/04/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $73.99 | General |
| Category: SURGERY | ||||||
| 07/10/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $93.75 | General |
| Category: SURGERY | ||||||
| 07/10/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $61.91 | General |
| Category: SURGERY | ||||||
| 07/09/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $61.92 | General |
| Category: SURGERY | ||||||
| 05/07/2019 | DySIS Medical, Inc. | Ultra 2.0 (Device) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: OBSTETRICS & GYNECOLOGY | ||||||
| 02/25/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Oncology | ||||||
| 02/21/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Oncology | ||||||
| 02/11/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2018 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: BioOncology | ||||||
| 09/11/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Oncology | ||||||
| 08/30/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2018 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: BioOncology | ||||||
| 06/07/2018 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 1,006 | 20,586 | $2.9M | $497,181 |
| 2022 | 25 | 825 | 10,459 | $1.4M | $485,303 |
| 2021 | 32 | 972 | 30,736 | $2.6M | $1.1M |
| 2020 | 28 | 818 | 21,771 | $977,117 | $309,224 |
Total Patients
3,621
Total Services
83,552
Medicare Billing
$2.4M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 13 | 4,600 | $670,800 | $189,285 | 28.2% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 12 | 2,077 | $444,385 | $117,155 | 26.4% |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 2023 | 26 | 612 | $883,728 | $46,596 | 5.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 287 | $114,800 | $26,641 | 23.2% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 34 | 34 | $102,204 | $26,292 | 25.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 67 | 177 | $93,810 | $25,653 | 27.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 48 | 168 | $115,248 | $17,743 | 15.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $36,580 | $7,599 | 20.8% |
| 38570 | Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | Facility | 2023 | 21 | 21 | $37,548 | $4,895 | 13.0% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 29 | 87 | $29,058 | $4,598 | 15.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 41 | 172 | $26,144 | $4,034 | 15.4% |
| 56820 | Exam of external female genitals using an endoscope | Office | 2023 | 24 | 37 | $13,653 | $3,513 | 25.7% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2023 | 21 | 21 | $8,904 | $2,914 | 32.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $11,400 | $2,753 | 24.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 20 | $15,000 | $2,743 | 18.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 24 | $9,120 | $2,379 | 26.1% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 35 | 179 | $18,795 | $2,266 | 12.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 34 | $9,180 | $2,010 | 21.9% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 16 | 60 | $9,360 | $1,405 | 15.0% |
| 57420 | Exam of vagina and cervix using an endoscope | Office | 2023 | 12 | 12 | $4,620 | $1,264 | 27.4% |
| 58100 | Biopsy of lining of uterus | Office | 2023 | 12 | 12 | $4,236 | $1,009 | 23.8% |
| J9045 | Injection, carboplatin, 50 mg | Office | 2023 | 24 | 426 | $127,800 | $831.44 | 0.7% |
| J9267 | Injection, paclitaxel, 1 mg | Office | 2023 | 15 | 7,956 | $12,366 | $826.92 | 6.7% |
| 96377 | Application of on-body injector for under skin injection | Office | 2023 | 26 | 50 | $2,450 | $731.04 | 29.8% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 25 | 790 | $96,380 | $663.50 | 0.7% |
About Dr. Nikki Neubauer, M.D
Dr. Nikki Neubauer, M.D is a Gynecologic Oncology healthcare provider based in Oak Lawn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1598975336.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nikki Neubauer, M.D has received a total of $1,051 in payments from pharmaceutical and medical device companies, with $47.92 received in 2024. These payments were reported across 41 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($988.71).
As a Medicare-enrolled provider, Neubauer has provided services to 3,621 Medicare beneficiaries, totaling 83,552 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Location Oak Lawn, IL
- Active Since 05/23/2007
- Last Updated 08/25/2020
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1598975336
Products in Payments
- Da Vinci Surgical System (Device) $291.57
- Avastin (Biological) $132.08
- ZEJULA (Drug) $96.80
- MynxGrip Vascular Closure Device (Device) $68.73
- KEYTRUDA (Biological) $63.04
- LYNPARZA (Drug) $61.52
- FASLODEX (Drug) $32.53
- MYRISK (Device) $28.87
- Rubraca (Drug) $25.59
- PreciseTumor (Device) $23.48
- YONDELIS (Drug) $22.99
- Lenvima (Drug) $22.35
- TIVDAK (Biological) $22.05
- Neulasta (Biological) $17.33
- INJECTAFER (Drug) $16.77
- SANCUSO (Drug) $14.97
- Fulphila (Biological) $14.83
- Ultra 2.0 (Device) $13.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Oak Lawn
Alfred Guirguis, D.o, D.O
Gynecologic Oncology — Payments: $95,309
Gynecologic Oncology $95,309
Michael Lowe, Md, MD
Gynecologic Oncology — Payments: $9,767
Gynecologic Oncology $9,767
Yvonne Collins, Md, Facog, MD, FACOG
Gynecologic Oncology — Payments: $9,236
Gynecologic Oncology $9,236
Molly Ramaswami, Md, MD
Gynecologic Oncology — Payments: $935.95
Gynecologic Oncology $935.95
Carrie Mcilwain, Md, MD
Gynecologic Oncology — Payments: $842.15
Gynecologic Oncology $842.15